Skip to main content
. 2021 Nov 15;40(1):122–132. doi: 10.1016/j.vaccine.2021.11.026

Table 2.

Last survey responses for COVID-19 vaccine uptake, when it becomes available, from unique participants.*

Intent to Be Vaccinated, n (%)
Resident
Staff
No
n = 189 (28.1%)
Yes
n = 361 (53.7%)
Undecided
n = 118 (17.6%)
Received vaccine
n = 4 (0.6%)
Total
n = 672
P-value No
n = 42 (14.1%)
Yes
n = 167 (56.2%)
Undecided
n = 49 (16.5%)
Received
vaccine
n = 39 (13.1%)
Total
n = 297
P-value
Median age [Range] 36.0 [18.0, 80.0] 45.0 [18.0, 85.0] 38.0 [18.0, 72.0] 48.5 [41.0, 51.0] 41.0 [18.0, 85.0] <0.001 38.5 [20.0, 68.0] 29.0 [18.0, 78.0] 40.0 [21.0, 71.0] 31.0 [21.0, 81.0] 33.0 [18.0, 81.0] 0.004
Age group
 18–49 y 142 (31.8%) 212 (47.4%) 90 (20.1) 3 (0.7%) 447 (66.5%) 0.001 35 (14.5%) 139 (57.7%) 37 (15.4%) 30 (12.4%) 241 (81.1%) 0.33
 50–64 y 35 (20%) 118 (67.4%) 21 (12%) 1 (0.6%) 175 (26.0%) 6 (13.3%) 23 (51.1%) 11 (24.4%) 5 (11.1%) 45 (15.2%)
 ≥65 y 12 (24%) 31 (62%) 7 (14%) 0 (0%) 50 (7.44%) 1 (9.1%) 5 (45.5%) 1 (9.1%) 4 (36.4%) 11 (3.70%)
Race
 American Indian/ Alaska Native 9 (34.6%) 11 (42.3%) 5 (19.2%) 1 (3.8%) 26 (4.50%) 0.001 1 (25.0%) 1 (25.0%) 2 (50.0%) 0 (0.0%) 4 (1.44%) <0.001
 Asian 2 (11.1%) 15 (83.3%) 1 (5.6%) 0 (0.0%) 18 (3.11%) 3 (10.3%) 19 (65.5%) 3 (10.3%) 4 (13.8%) 29 (10.4%)
 Black/African American 75 (34.7%) 100 (46.3%) 39 (18.1%) 2 (0.9%) 216 (37.4%) 29 (39.7%) 16 (21.9%) 20 (27.4%) 8 (11.0%) 73 (26.3%)
 Multiple 21 (44.7%) 19 (40.4%) 7 (14.9%) 0 (0.0%) 47 (8.13%) 0 (0.0%) 11 (64.7%) 2 (11.8%) 4 (23.5%) 17 (6.12%)
 Native Hawaiian/ Pacific Islander 14 (37.8%) 17 (45.9%) 6 (16.2%) 0 (0.0%) 37 (6.40%) 0 (0.0%) 2 (28.6%) 4 (57.1%) 1 (14.3%) 7 (2.52%)
 White 46 (19.7%) 145 (62.0%) 43 (18.4%) 0 (0.0%) 234 (40.5%) 7 (4.7%) 108 (73.0%) 11 (7.4%) 22 (14.9%) 148 (53.2%)
Hispanic or Latino 19 (19.0%) 61 (61.0%) 20 (20.0%) 0 (0%) 100 (15.2%) 0.12 1 (3.4%) 17 (58.6%) 8 (27.6%) 3 (10.3%) 29 (9.90%) 0.13
Male 113 (27.4%) 244 (59.2%) 54 (13.1%) 1 (0.2%) 412 (63.6%) <0.001 10 (9.4%) 70 (66.0%) 13 (12.3%) 13 (12.3%) 106 (36.4%) 0.06
Duration of homelessness
 ≤6 months 60 (32.8%) 87 (47.5%) 35 (19.1%) 1 (0.5%) 183 (28.7%) 0.24 NA NA NA NA NA NA
 7–12 months 34 (35.8%) 46 (48.4%) 15 (15.8%) 0 (0.0%) 95 (14.9%) NA NA NA NA NA
 13–24 months 20 (27.4%) 42 (57.5%) 10 (13.7%) 1 (1.4%) 73 (11.4%) NA NA NA NA NA
 ≥24 months 68 (23.7%) 171 (59.6%) 46 (16.0%) 2 (0.7%) 287 (45.0%) NA NA NA NA NA
Highest education
 Less than high school 42 (30.0%) 75 (53.6%) 23 (16.4%) 0 (0.0%) 140 (21.6%) 0.02 1 (12.5%) 4 (50.0%) 3 (37.5%) 0 (0.0%) 8 (2.70%) <0.001
 High school / GED 74 (27.4%) 139 (51.5%) 55 (20.4%) 2 (0.7%) 270 (41.6%) 18 (30.0%) 25 (41.7%) 14 (23.3%) 3 (5.0%) 60 (20.3%)
 Some college 55 (28.1%) 112 (57.1%) 29 (14.8%) 0 (0.0%) 196 (30.2%) 14 (19.7%) 33 (46.5%) 20 (28.2%) 4 (5.6%) 71 (24.0%)
 Bachelors or higher 9 (20.9%) 28 (65.1%) 4 (9.3%) 2 (4.7%) 43 (6.63%) 9 (5.7%) 105 (66.9%) 11 (7.0%) 32 (20.4%) 157 (53.0%)
Employed 35 (32.1%) 51 (46.8%) 23 (21.1%) 0 (0.0%) 109 (16.2%) 0.30 41 (14.7%) 150 (54.0%) 49 (17.6%) 38 (13.7%) 278 (93.6%) 0.02
Health insurance 148 (26.9%) 305 (55.4%) 95 (17.2%) 3 (0.5%) 551 (85.2%) 0.20 40 (14.3%) 157 (56.1%) 45 (16.1%) 38 (13.6%) 280 (95.6%) 0.99
Underlying medical conditions (≥1) 40 (20.6%) 111 (57.2%) 40 (20.6%) 3 (1.5%) 194 (28.9%) 0.01 7 (11.1%) 38 (60.3%) 12 (19.0%) 6 (9.5%) 63 (21.2%) 0.64
Median enrollments per unique participant [Range] 2.00 [1.00, 31.0] 2.00 [1.00, 27.0] 2.00 [1.00, 25.0] 12.0 [3.00, 16.0] 2.00 [1.00, 31.0] 0.05 1.50 [1.00, 15.0] 2.00 [1.00, 15.0] 2.00 [1.00, 20.0] 6.00 [1.00, 16.0] 2.00 [1.00, 20.0] <0.001
Ever tested SARS-CoV-2 positive 13 (19.7%) 40 (60.6%) 12 (18.2%) 1 (1.5%) 66 (10.4%) 0.25 3 (21.4%) 6 (42.9%) 1 (7.1%) 4 (28.6%) 14 (5.05%) 0.20
Reason for no COVID-19 vaccine
 Concerns about vaccine safety 60 (72.3%) NA 23 (27.7%) NA 83 (29.4%) <0.001 14 (38.9%) NA 22 (61.1%) NA 36 (41.9%) 0.005
 Need more information 21 (28.8%) NA 52 (71.2%) NA 73 (25.9%) 6 (26.1%) NA 17 (73.9%) NA 23 (26.7%)
 Not worried about COVID-19 8 (72.7%) NA 3 (27.3%) NA 11 (3.90%) 1 (50.0%) NA 1 (50.0%) NA 2 (2.33%)
 Not enough time 1 (50.0%) NA 1 (50.0%) NA 2 (0.71%) 0 (0.0%) NA 0 (0.0%) NA 0 (0.0%)
 Already had COVID-19 3 (100.0%) NA 0 (0.0%) NA 3 (1.06%) 1 (100.0%) NA 0 (0.0%) NA 1 (1.16%)
 Want to prioritize high-risk persons 1 (100.0%) NA 0 (0.0%) NA 1 (0.35%) 1 (33.3%) NA 2 (66.7%) NA 3 (3.49%)
 Unlisted reason 81 (74.3%) NA 28 (25.7%) NA 109 (38.7%) 18 (72.0%) NA 7 (28.0%) NA 21 (24.4%)
Received this season's flu vaccine 56 (19.2%) 196 (67.4%) 37 (12.7%) 2 (0.7%) 291 (45.0%) <0.001 9 (5.4%) 107 (63.7%) 20 (11.9%) 32 (19.0%) 168 (57.5%) <0.001
Reason for no flu vaccine
 Concerns about vaccine safety 32 (51.6%) 18 (29.0%) 12 (19.4%) 0 (0.0%) 62 (19.4%) <0.001 4 (50.0%) 1 (12.5%) 2 (25.0%) 1 (12.5%) 8 (7.02%) 0.02
 Not worried about flu 10 (35.7%) 8 (28.6%) 10 (35.7%) 0 (0.0%) 28 (8.78%) 8 (50.0%) 3 (18.8%) 4 (25.0%) 1 (6.2%) 16 (14.0%)
 I plan to get the flu vaccine 6 (12.8%) 26 (55.3%) 15 (31.9%) 0 (0.0%) 47 (14.7%) 2 (6.9%) 21 (72.4%) 4 (13.8%) 2 (6.9%) 29 (25.4%)
 Other reason§ 72 (39.6%) 83 (45.6%) 26 (14.3%) 1 (0.5%) 182 (57.1%) 16 (26.2%) 27 (44.3%) 15 (24.6%) 3 (4.9%)
  • 61

    (53.5%)

*

Excludes participants that responded “Prefer not to say” when asked about vaccination intent.

All columns apart from “Total” have calculated row percentages; “Total” column percentages calculated exclude missing responses.

Underlying conditions include asthma, blood disorders, cancer, chronic obstructive pulmonary disease or emphysema, immunosuppression, liver disease, heart disease, diabetes, neurologic conditions or aspirin therapy.

§

Aggregated responses: “Do not have the time to get vaccinated” (n = 29); “Not required for work or school” (n = 2); “Not recommended by a doctor or healthcare worker” (n = 2); “Not covered by health insurance” (n = 3); “Not offered at a convenient location” (n = 12); “None of the above” (n = 195).